GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer

被引：0
|
作者：
Lilin Wan
Yifan Liu
Ruiji Liu
Weipu Mao
机构：
[1] People’s Hospital of Putuo District,Department of Urology
[2] Affiliated Zhongda Hospital of Southeast University,Department of Urology
[3] Southeast University,Department of Urology, Sichuan Provincial People’s Hospital
[4] School of Medicine,undefined
[5] University of Electronic Science and Technology of China,undefined
来源：
Cancer Cell International | / 23卷
关键词：
GAD1; Prostate cancer; Castration resistant; Drug resistance; Immune;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling
    Lescarbeau, Reynald M.
    Kaplan, David L.
    BMC CANCER, 2014, 14
  • [32] Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
    Mai, Lixin
    Zhang, Zitong
    Li, Yonghong
    Liu, Ruiqi
    Li, Jibin
    Huang, Sijuan
    Lin, Maosheng
    Liu, Boji
    Cao, Wufei
    Wu, Jianhua
    Liu, Mengzhong
    Zhou, Fangjian
    Liu, Yang
    He, Liru
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Castration Resistant Prostate Cancer 2011
    Miller, K.
    AKTUELLE UROLOGIE, 2011, 42 (02) : 95 - 102
  • [34] MANAGEMENT OF NON METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Munoz-Velez, Daniel
    ARCHIVOS ESPANOLES DE UROLOGIA, 2015, 68 (02): : 125 - 134
  • [35] Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives
    Lassi, Kiran
    Dawson, Nancy A.
    FUTURE ONCOLOGY, 2011, 7 (04) : 551 - 558
  • [36] Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
    Kong, Yifan
    Cheng, Lijun
    Mao, Fengyi
    Zhang, Zhuangzhuang
    Zhang, Yanquan
    Farah, Elia
    Bosler, Jacob
    Bai, Yunfeng
    Ahmad, Nihal
    Kuang, Shihuan
    Li, Lang
    Liu, Xiaoqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (37) : 14328 - 14341
  • [37] Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide
    Modena, Alessandra
    Ciccarese, Chiara
    Fantinel, Emanuela
    Bimbatti, Davide
    Tortora, Giampaolo
    Massari, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1037 - 1048
  • [38] Castration Resistant Prostate Cancer 2015
    Merseburger, A. S.
    Boeker, A.
    Kuczyk, M. A.
    von Klot, C. -A.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 59 - 65
  • [39] T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance
    Dasen, Boris
    Vlajnic, Tatjana
    Mengus, Chantal
    Ruiz, Christian
    Bubendorf, Lukas
    Spagnoli, Giulio
    Wyler, Stephen
    Erne, Paul
    Resink, Therese J.
    Philippova, Maria
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2017, 3 (01) : 44 - 57
  • [40] Metastasic Prostate Cancer: Predictive Factors of Earlier Progression to Castration-Resistance
    Dellavedova, Tristan
    Malizia, Enzo
    Quinteros, Leandro
    Nobile, Raul
    Minuzzi, Federico
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (05): : 430 - 434
12345